Year None20222021202020192018 05.16.22 Terns Pharmaceuticals Reports First Quarter 2022 Financial Results and Business Updates 04.4.22 Terns Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference 03.21.22 Terns Reports Top-line Results from Phase 1 AVIATION Trial of VAP-1 Inhibitor TERN-201 03.3.22 Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights 02.28.22 Terns Pharmaceuticals to Participate in the Cowen 42nd Annual Healthcare Conference 01.6.22 Terns Pharmaceuticals Appoints Jeffrey R. Jasper, Ph.D., as Senior Vice President, Head of Research and Promotes Diana Chung to Senior Vice President, Chief Development Officer 01.3.22 Terns Pharmaceuticals to Present at 40th Annual J.P. Morgan Health Care Conference
03.3.22 Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
01.6.22 Terns Pharmaceuticals Appoints Jeffrey R. Jasper, Ph.D., as Senior Vice President, Head of Research and Promotes Diana Chung to Senior Vice President, Chief Development Officer
